To slow things down, I think of basal cell carcinomas.

A statement from his office said the cancer was basal cell carcinoma.

The skin cancer he has was probably a little basal cell carcinoma.

Basal cell carcinoma is the most common type of skin cancer.

Basal cell carcinomas may develop around the age of 35.

It turned out to be basal cell carcinoma, a form of skin cancer caused by the sun.

It took several days before he acknowledged that a basal cell carcinoma had been removed.

Basal cell carcinomas grow slowly, taking months or even years to become sizable.

The most common eyelid tumor is called basal cell carcinoma.

Basal cell carcinoma has a tendency to be locally destructive.

Signs of basal cell carcinoma can include skin changes such as a:

When treating superficial basal cell carcinoma, apply 5 times a week for a full 6 weeks.

Basal cell carcinomas are present on sun-exposed areas of the skin, especially the face.

Two more basal cell carcinomas developed on his face, one of them requiring plastic surgery three months ago.

Basal cell carcinoma usually affects the head, neck, back, chest, or shoulders.

Because basal cell carcinoma spreads slowly it occurs mostly in adults.

It may also be instrumental in the destruction of skin cancers such as basal cell carcinoma.

That something was a basal cell carcinoma, the most common and least dangerous skin cancer, usually caused by sun exposure.

This method is most frequently applied to the superficial type of basal cell carcinoma.

The severity of the basal cell carcinoma determines the prognosis for most patients.

The majority of these are basal cell carcinomas.

There is little evidence that it is effective in preventing basal cell carcinoma.

Diseases associated with the malfunction of this pathway include basal cell carcinoma.

Its appearance is similar to basal cell carcinoma.

Treatment of basal cell carcinoma may include the following:

The most common, basal-cell carcinoma, is considered a benign malignancy.

Up to 30% of Caucasians develop basal-cell carcinomas in their lifetime.

This pathway is pathogenetically relevant in more than 90% of basal-cell carcinomas.

Superficial basal-cell carcinoma, or some might consider to be equivalent to "in-situ".

Off label use of imiquimod on invasive basal-cell carcinoma has been reported.

In April 2011 Brown had surgery to remove a basal-cell carcinoma from the right side of his nose.

To diagnose basal-cell carcinomas, a skin biopsy is taken for pathological study.

As suspected, I had a confirmed basal-cell carcinoma.

However, farmers and fishermen and others who are always in the sun get many basal-cell carcinomas on exposed parts of their bodies.

For simplicity, one can also divide basal-cell carcinoma into 3 groups, based on location and difficulty of therapy:

About two thirds of basal-cell carcinomas occur on sun-exposed areas of the body.

Serious adverse events in the fingolimod group included bradycardia, relapse, and basal-cell carcinoma.

Basal-cell carcinomas are differentiated toward the folliculo-sebaceous-apocrine germ, also known as the trichoblast.

Although basal-cell carcinoma rarely metastasizes, it grows locally with invasion and destruction of local tissues.

About 750,000 Americans develop basal-cell carcinoma tumors each year, according to the National Cancer Institute.

Basal-cell carcinoma is highly curable with surgery, if found and treated early, and tends not to spread to other parts of the body, experts say.

The following two years brought two more episodes, all diagnosed as basal-cell carcinoma, needing surgical excision or radiation treatments.

Finding similar mutations in patients who developed basal-cell carcinoma in different ways pointed to the role of the gene in the cancer, the researchers said.

Basal-cell carcinoma (BCC), a skin cancer, is the most common cancer.

The following methods are employed in the treatment of basal-cell carcinoma (BCC):

The most common cause (etiology) for a nasal reconstruction is skin cancer, especially the lesions to the nose of melanoma and basal-cell carcinoma.

Micronodular basal-cell carcinoma is a cutaneous condition characterized by a micronodular growth pattern.

Infiltrative basal-cell carcinoma, which often encompasses morpheaform and micronodular basal-cell cancer.

Nodular basal-cell carcinoma, which essentially includes most of the remaining categories of basal-cell cancer.

Both Imiquimod and 5-fluorouracil have received FDA approval for the treatment of superficial basal-cell carcinoma.